Fernández Val J F, Losada J, Arregui Murua M A, Sarría R
Department of Surgery, School of Medicine, Hospital Cruces, University of Pai;s Vasco, Bilbao, Spain.
Cancer Genet Cytogenet. 2002 Oct 1;138(1):69-72. doi: 10.1016/s0165-4608(02)00567-8.
The purpose of this work was to study if the variations in the nuclear DNA content and the expression of EGFr and HER2/neu transmembrane oncoproteins were related and if this influences the rate of cell proliferation modifying, in each case, the potential aggressivity of the neoplasia. Thirty-four ductal breast carcinoma tissue samples of tumors of up to 2 cm in diameter were analyzed by flow cytometry. HER2/neu and EGFr were measured by immunohistochemical methods. Twenty cases were diploid (DNA index of 1) and 14 cases were aneuploid (DNA index other than 1). The expression of EGFr and HER2/neu was significantly higher in aneuploid tumors compared with diploid tumors. The cell proliferation rate was significantly higher in tumors with an aneuploid pattern. The expression of EGFr was associated with a higher rate of cell proliferation. The higher expression of EGFr and HER 2/neu oncoproteins in aneuploid tumors suggests that the increased proliferative activity of aneuploid carcinomas is influenced by the activity of such oncoproteins, which favors a more aggressive biological behavior.
本研究的目的是探讨核DNA含量的变化以及EGFr和HER2/neu跨膜癌蛋白的表达是否相关,以及这是否会影响细胞增殖速率,进而在每种情况下改变肿瘤的潜在侵袭性。采用流式细胞术分析了34例直径达2 cm的乳腺导管癌组织样本。通过免疫组化方法检测HER2/neu和EGFr。20例为二倍体(DNA指数为1),14例为非整倍体(DNA指数不为1)。与二倍体肿瘤相比,非整倍体肿瘤中EGFr和HER2/neu的表达明显更高。非整倍体模式的肿瘤细胞增殖速率明显更高。EGFr的表达与较高的细胞增殖速率相关。非整倍体肿瘤中EGFr和HER 2/neu癌蛋白的高表达表明,非整倍体癌增殖活性的增加受此类癌蛋白活性的影响,这有利于更具侵袭性的生物学行为。